A much diminished 23andMe exists today, a far cry from the phenomenon that it was in the world consumer DNA testing. Could things have unfolded differently under a different leader with a different vision?
Act fast! Advance Rate Tickets for MedCity INVEST 2024 end on April 26. Connect with industry leaders, explore cutting-edge investment trends, and create lasting relationships at this exclusive event. Secure your spot today and get ready to unlock new opportunities in healthcare innovation!
Medicare's Chronic Care Management program reduced emergency room and in-patient hospital visits and lowered total health spending, but uptake has been sluggish for a variety of reasons.
Cerevel Therapeutics drug tavapadon met the main and secondary goals of a pivotal Parkinson's disease clinical trial. That drug and others will join the neuroscience portfolio of AbbVie, which is in the process of acquiring Cerevel.
Q1 2024 saw a significant rise in the number of hospital M&A deals compared to the past three Q1s. Experts believe this M&A activity will continue to climb throughout this year and next — motivated by both financial distress and hospitals' desire to improve strategic business lines like value-based care and digital healthcare services.
Included Health's new specialty care clinic, which will become available in 2025, is starting by offering three centers: the Cancer Center, the Center for Women's Health and the Center for Metabolic Health.
In this month's episode, Senior Reporter Katie Adams discussed some executive hires, promotions and departures that recently occurred in the healthcare world, as well as layoffs affecting the industry. We also hear from Brian Anderson, who recently became CEO of the Coalition for Health AI (CHAI).
No comments